Calcium alters monoamine oxidase-A parameters in human cerebellar and rat glial C6 cell extracts: Possible influence by distinct signalling pathways

Life Sciences

Volumn 85, Issue 5-6, 2009, Pages 262-268

  Cao, Xia ^a   Li, Xin Min ^b   Mousseau, Darrell D ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Akt; Alzheimer's disease; Calcium; Cancer; Contact inhibition; Monoamine oxidase; p38 MAP kinase; p42 44; Post translational modification

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CALCIUM ION; MAGNESIUM ION; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN CANCER; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GLIA CELL; HUMAN; HUMAN TISSUE; MALE; NERVE DEGENERATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RAT; SIGNAL TRANSDUCTION; TRANSLATION REGULATION;

AGED; ANIMALS; BINDING SITES; CALCIUM; CALCIUM SIGNALING; CELL LINE, TUMOR; CEREBELLUM; GENE EXPRESSION; GLIOBLASTOMA; HUMANS; MALE; MICE; MIDDLE AGED; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NEUROGLIA; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN BINDING; RATS; RNA, MESSENGER; THIAZOLES;

RATTUS;

EID: 67649970490     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.06.004     Document Type: Article

References (45)

1. Altura B.M. Calcium antagonist properties of magnesium: implications for antimigraine actions. Magnesium 4 4 (1985) 169-175
2. 2 in vascular smooth muscle cells: potential involvement in vascular disease (review). International Journal of Molecular Medicine 11 2 (2003) 229-234
3. 2-induced activation of ERK1/2, p38 MAPK, and protein kinase B signaling in vascular smooth muscle cells. Antioxidants & Redox Signaling 6 2 (2004) 353-366
4. Bu J., Sathyendra V., Nagykery N., and Geula C. Age-related changes in calbindin-D28k, calretinin, and parvalbumin-immunoreactive neurons in the human cerebral cortex. Experimental Neurology 182 1 (2003) 220-231
5. Bulavin D.V., Higashimoto Y., Popoff I.J., Gaarde W.A., Basrur V., Potapova O., Appella E., and Fornace Jr. A.J. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 411 6833 (2001) 102-107
6. Cao X., Wei Z., Gabriel G.G., Li X., and Mousseau D.D. Calcium-sensitive regulation of monoamine oxidase-A contributes to the production of peroxyradicals in hippocampal cultures: implications for Alzheimer disease-related pathology. BMC Neuroscience 8 (2007) 73
7. 3H]Ro 41-1049 to the active site of human monoamine oxidase-A. Molecular Pharmacology 37 3 (1990) 358-366
8. 1A receptors. Life Sciences 76 4 (2004) 429-443
9. De Zutter G.S., and Davis R.J. Pro-apoptotic gene expression mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Proceedings of the National Academy of Sciences (USA) 98 11 (2001) 6168-6173
10. 2+ transport by mammalian mitochondria and its role in hormone action. American Journal of Physiology 249 6 Pt 1 (1985) E543-554
11. Duchen M.R. Contributions of mitochondria to animal physiology: from homeostatic sensor to calcium signalling and cell death. Journal of Physiology 516 Pt 1 (1999) 1-17
12. +: implications for neurodegeneration. Journal of Neurochemistry 63 2 (1994) 584-591
13. Egashira T., Sakai K., Sakurai M., and Takayama F. Calcium disodium edetate enhances type A monoamine oxidase activity in monkey brain. Biological Trace Element Research 94 3 (2003) 203-211
14. Faust D., Dolado I., Cuadrado A., Oesch F., Weiss C., Nebreda A.R., and Dietrich C. p38α MAPK is required for contact inhibition. Oncogene 24 53 (2005) 7941-7945
15. Fitzgerald J.C., Ufer C., and Billett E.E. A link between monoamine oxidase-A and apoptosis in serum deprived human SH-SY5Y neuroblastoma cells. Journal of Neural Transmission 114 6 (2007) 807-810
16. Gatz M., Reynolds C.A., Fratiglioni L., Johansson B., Mortimer J.A., Berg S., Fiske A., and Pedersen N.L. Role of genes and environments for explaining Alzheimer disease. Archives of General Psychiatry 63 2 (2006) 168-174
17. Geula C., Nagykery N., Wu C.K., and Bu J. Loss of calbindin-D28K from aging human cholinergic basal forebrain: relation to plaques and tangles. Journal of Neuropathology and Experimental Neurology 62 6 (2003) 605-616
18. 2+ loads from rat adrenal chromaffin cells. Neuron 16 1 (1996) 219-228
19. Holt A., and Baker G.B. Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine. Naunyn-Schmiedebergs Archives of Pharmacology 354 1 (1996) 17-24
20. Jenner P. Oxidative stress in Parkinson's disease and other neurodegenerative disorders. Pathologie Biologie (Paris) 44 1 (1996) 57-64
21. Kabuto H., Yokoi I., Mori A., Murakami M., and Sawada S. Neurochemical changes related to ageing in the senescence-accelerated mouse brain and the effect of chronic administration of nimodipine. Mechanisms of Ageing and Development 80 1 (1995) 1-9
22. Kakkar P., Mehrotra S., and Viswanathan P.N. Interrelation of active oxygen species, membrane damage and altered calcium functions. Molecular and Cellular Biochemistry 111 1-2 (1992) 11-15
23. Kennedy B.P., Ziegler M.G., Alford M., Hansen L.A., Thal L.J., and Masliah E. Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease. Journal of Neural Transmission 110 7 (2003) 789-801
24. Kirischuk S., Pronchuk N., and Verkhratsky A. Measurements of intracellular calcium in sensory neurons of adult and old rats. Neuroscience 50 4 (1992) 947-951
25. Konradi C., Riederer P., and Youdim M.B. Hydrogen peroxide enhances the activity of monoamine oxidase type-B but not of type-A: a pilot study. Journal of Neural Transmission Suppl 22 (1986) 61-73
26. Kosenko E.A., Venediktova N.I., and Kaminskii Iu G. Calcium and ammonia stimulate monoamine oxidase A activity in brain mitochondria. Izvestiia Akademii nauk. Seriia biologicheskaia 5 (2003) 542-546
27. Kruman I.I., and Mattson M.P. Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis. Journal of Neurochemistry 72 2 (1999) 529-540
28. Maher P., and Davis J.B. The role of monoamine metabolism in oxidative glutamate toxicity. Journal of Neuroscience 16 20 (1996) 6394-6401
29. Malorni W., Giammarioli A.M., Matarrese P., Pietrangeli P., Agostinelli E., Ciaccio A., Grassilli E., and Mondovi B. Protection against apoptosis by monoamine oxidase A inhibitors. FEBS Letters 426 1 (1998) 155-159
30. 2+ transients that modulate secretion. Nature Cell Biology 2 2 (2000) 57-61
31. Mousseau D.D., Baker G.B., and Butterworth R.F. Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy. Journal of Neurochemistry 68 3 (1997) 1200-1208
32. Ou X.M., Chen K., and Shih J.C. Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. Proceedings of the National Academy of Sciences (USA) 103 29 (2006) 10923-10928
33. Rao V.L. Nitric oxide in hepatic encephalopathy and hyperammonemia. Neurochemistry International 41 2-3 (2002) 161-170
34. 2+: molecular determinants and functional consequences. Physiological Reviews 86 1 (2006) 369-408
35. Rybaczyk L.A., Bashaw M.J., Pathak D.R., and Huang K. An indicator of cancer: downregulation of monoamine oxidase-A in multiple organs and species. BMC Genomics 9 (2008) 134
36. Samantaray S., Chandra G., and Mohanakumar K.P. Calcium channel agonist, (+/-)-Bay K8644, causes a transient increase in striatal monoamine oxidase activity in Balb/c mice. Neuroscience Letters 342 1-2 (2003) 73-76
37. Shi Y.Y., Small G.W., and Orlowski R.Z. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer. Breast Cancer Research and Treatment 100 1 (2006) 33-47
38. Shih J.C. Molecular basis of human MAO A and B. Neuropsychopharmacology 4 1 (1991) 1-7
39. Shih J.C., Chen K., and Ridd M.J. Monoamine oxidase: from genes to behavior. Annual Review of Neuroscience 22 (1999) 197-217
40. Traboulsie A., Chemin J., Kupfer E., Nargeot J., and Lory P. T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine. Molecular Pharmacology 69 6 (2006) 1963-1968
41. Ward M.W., Kushnareva Y., Greenwood S., and Connolly C.N. Cellular and subcellular calcium accumulation during glutamate-induced injury in cerebellar granule neurons. Journal of Neurochemistry 92 5 (2005) 1081-1090
42. 2+ following intense glutamate stimulation of cultured rat forebrain neurons. Journal of Physiology 498 Pt 1 (1997) 31-47
43. Wu C.K., Nagykery N., Hersh L.B., Scinto L.F., and Geula C. Selective age-related loss of calbindin-D28k from basal forebrain cholinergic neurons in the common marmoset (Callithrix jacchus). Neuroscience 120 1 (2003) 249-259
44. 2+ clearance in the cytosol of adrenal chromaffin cells. Biophysical Journal 73 1 (1997) 532-545
45. Zhu X., Raina A.K., Lee H.G., Chao M., Nunomura A., Tabaton M., Petersen R.B., Perry G., and Smith M.A. Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways. Antioxidants & Redox Signaling 5 5 (2003) 571-576